title: Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
abstract: OBJECTIVE
  The objective of this study was to detail the epidemiologic characteristics and natural history of HIV-1 natural viral suppressors (NVSs), a cohort of HIV-1-infected individuals who are able to suppress viral replication to undetectable levels in the absence of therapy.
  
  
  METHODS
  HIV-1 patients who met the NVS criteria were enrolled into a prospective study. The incidence and prevalence of NVS were calculated by performing a chart review on all patients seen in 1 clinic in a 10-year period. Cumulative probability of progression-free survival was calculated by Kaplan-Meier product limit method.
  
  
  RESULTS
  Forty individuals enrolled in the study. The median year of diagnosis was 1994, and individuals demonstrated a median 6.7 years of HIV-1 viral suppression and CD4 count of 795 cells per microliter. NVS had an incidence of 1.1% [95% confidence interval (CI), 0.0 to 2.1] and prevalence of 1.5% (95% CI, 0.8 to 2.1). Only 1 patient (2.5%) has progressed. Within the first 10 years for follow-up having met the definition of NVS, 95.1% (95% CI 86.5% to 100%) of the NVS continued to control their viral loads to undetectable levels.
  
  
  CONCLUSIONS
  The NVS cohort has demonstrated remarkable stability and a low rate of progression over many years. Detailed evaluations of viral-host immune regulatory factors associated with persistent HIV-1 natural viral suppression, and loss of such suppression, has the potential to provide important new insight in HIV pathogenesis and future immune regulatory targeted preventive and therapeutic research.
authors.affiliation: Institute of Human Virology at the University of Maryland School of Medicine, Baltimore, MD, USA. msajadi@ihv.umaryland.edu
authors.forename: Mohammad M
authors.initials: MM
authors.lastname: Sajadi
authors.forename: Neil T
authors.initials: NT
authors.lastname: Constantine
authors.forename: Dean L
authors.initials: DL
authors.lastname: Mann
authors.forename: Manhattan
authors.initials: M
authors.lastname: Charurat
authors.forename: Elham
authors.initials: E
authors.lastname: Dadzan
authors.forename: Peter
authors.initials: P
authors.lastname: Kadlecik
authors.forename: Robert R
authors.initials: RR
authors.lastname: Redfield
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology* / Q000276:immunology / Q000401:mortality; D000328:Adult; D018791:CD4 Lymphocyte Count; D005260:Female; D015497:HIV-1; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged